Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’
Open Access
- 4 February 2021
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 82 (1), e23
- https://doi.org/10.1136/annrheumdis-2020-219312
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitisAnnals Of The Rheumatic Diseases, 2020
- SAT0570 CLINICAL SIGNIFICANCE OF FINGER EXTENSOR PARATENONITIS DETECTED BY MUSCULOSKELETAL ULTRASOUNDAnnals Of The Rheumatic Diseases, 2020
- LB004A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASENephrology Dialysis Transplantation, 2020
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated VasculitisThe New England Journal of Medicine, 2020
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisThe New England Journal of Medicine, 2010